This information was published on 2025-05-19T10:26:30 for IP Right Registration Published.
| Field | Value |
| (210) | 2509920 (IR 1830406) |
| (220) |
18 Jul 2024
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 1
Chemical testing for commercial and scientific purposes for detecting skin diseases, in particular for detecting skin diseases, predominantly consisting of chemical reagents, in particular containing oligonucleotides and/or antibodies for qualitatively and/or quantitatively determining the expression of biomarkers for detecting skin diseases, in particular for detecting psoriasis and/or atopic eczema and for distinguishing between psoriasis and atopic eczema. Class 5 Pharmaceuticals, in particular products for treating skin diseases, in particular for treating psoriasis and/or atopic eczema; diagnostic preparations for medical purposes, in particular in the field of dermatology, in particular in the field of diagnosing skin diseases, in particular for diagnosing dermato-oncological diseases or for diagnosing inflammatory skin diseases, in particular for diagnosing psoriasis and/or atopic eczema and for distinguishing between psoriasis and atopic eczema, in particular containing oligonucleotides and/or antibodies. Class 42 Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; services provided by a biochemical or pharmaceutical laboratory, in particular in the field of dermatology, in particular in the field of diagnosing skin diseases, in particular for diagnosing dermato-oncological diseases or for diagnosing inflammatory skin diseases, in particular for diagnosing psoriasis and/or atopic eczema and for distinguishing between psoriasis and atopic eczema. |
| (540) | dermagnostix |
| (550) | Word |
| (730) |
Dermagnostix R&D GmbH
|
Find out more about publications on the About page.